Viewing Study NCT00431067


Ignite Creation Date: 2025-12-25 @ 12:35 AM
Ignite Modification Date: 2025-12-25 @ 10:44 PM
Study NCT ID: NCT00431067
Status: COMPLETED
Last Update Posted: 2014-06-09
First Post: 2007-02-02
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab Therapy
Sponsor: Boehringer Ingelheim
Organization: